Home AB
40.48
  Price0.54%   -0.22
(After Hours: 40.48 +0.00 +0.00%)
loading

AllianceBernstein Holding L.P. (AB) Latest News

Nov-24-22 08:50AM AllianceBernstein and Societe Generale Plan to Form a JVZacks Investment Research
Nov-21-22 12:09PM AB Science a reçu l’approbation de la Food and Drug Administration (FDA) américaine pour initier une étude confirmatoire de phase 3 avec le masitinib dans le traitement de la maladie d’AlzheimerGlobeNewswire Inc.
Nov-15-22 09:42AM T. Rowe Price (TROW) Gains 17% on October AUM Rise to $1.28TZacks Investment Research
Nov-14-22 11:32AM Lazard's (LAZ) October AUM Rises 3.4% on Market AppreciationZacks Investment Research
11:26AM Virtus Investment (VRTS) Stock Gains 7.8% on October AUM RiseZacks Investment Research
Nov-10-22 11:17AM Invesco (IVZ) October AUM Rises 2.8% on Favorable MarketsZacks Investment Research
07:38AM AllianceBernstein (AB) Stock Up 1.7% as October AUM RisesZacks Investment Research
Oct-31-22 03:24AM 4 Analysts Have This to Say About AllianceBernstein HoldingBenzinga
10:25AM Analyst Ratings for AllianceBernstein HoldingBenzinga
Oct-31-22 09:59AM Where AllianceBernstein Holding Stands With AnalystsBenzinga
08:28AM Mastercard To $428? Plus This Analyst Slashes PT On IntelBenzinga
Oct-21-22 09:14AM Implied Volatility Surging for AllianceBernstein (AB) Stock OptionsZacks Investment Research
Oct-19-22 10:02AM Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022Benzinga
Oct-12-22 05:26AM Zacks.com featured highlights include Terns Pharmaceuticals, AllianceBernstein Holding and ALLETEZacks Investment Research
Oct-11-22 08:54AM 3 Stocks for Higher Returns as New Analysts Initiate CoverageZacks Investment Research
Oct-10-22 12:04PM AB Science a reçu les premières autorisations règlementaires pour initier une étude clinique confirmatoire de phase 3 avec le masitinib dans le traitement de la maladie d’AlzheimerGlobeNewswire Inc.
Sep-30-22 12:39PM AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2022 et présente un point sur ses activitésGlobeNewswire Inc.
Sep-15-22 11:22AM Lazard's (LAZ) August AUM Slips 3.6% on Market DepreciationZacks Investment Research
Sep-14-22 12:21PM AB Science - Recommandation favorable du comité indépendant de revue des données de poursuivre l’étude de Phase 2 évaluant l’activité antivirale du masitinib dans le traitement du Covid-19GlobeNewswire Inc.
Sep-13-22 09:54AM Invesco's (IVZ) August AUM Down on Unfavorable Market ReturnsZacks Investment Research
Sep-05-22 08:00AM NVIDIA Draws Attention To Pelosi's Stock PicksInvesting.com
Aug-29-22 12:45PM Meet the Most Trusted Financial companies in 2022, according to MarketWatch, IBD surveyMarketWatch
Aug-24-22 01:07AM AB Science annonce avoir déposé une demande d'autorisation de mise sur le marché conditionnelle auprès de l’EMA pour le masitinib dans le traitement de la SLAGlobeNewswire Inc.
Aug-12-22 06:55AM AllianceBernstein (AB) Stock Up 2.3% as July AUM Rises 6.5%Zacks Investment Research
Jun-07-22 11:45AM AB Science annonce aujourd'hui la publication des résultats de son étude positive du masitinib dans l'asthme sévère non contrôlé par les corticostéroïdes oraux dans la revue évaluée par des pairs Journal of Asthma and AllergyGlobeNewswire Inc.
AllianceBernstein Holding L.P. is publicly owned investment manager. The firm also provides research services to its clients. It provides its services to investment companies, pension and profit sharing plans, banks and thrift institutions, trusts, estates, government agencies, charitable organizations, individuals, corporations, and other business entities. The firm invests in public equity, fixed income, and alternative investment markets across the globe. It employs long/short strategy to make its investments. The firm conducts in-house research to make its investments. AllianceBernstein Holding L.P. was founded in 1987 and is based in New York, New York.
Cap:    |  Volume (24h):